UNSPSC 51271503: Hyaluronidase

This classification denotes an adjuvant with the molecular formula C2327H3553N589O667S20, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8KOG53Z5EM, more generally known as hyaluronidase. European Medicines Agency schedules hyaluronidase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02552MIG. The term HYALURONIDASE is an International Non-Proprietary Name or INN. HYALURONIDASE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule hyaluronidase under HS 35079090 and SITC 51691. As of Q4 2014, HYALURONIDASE remains the US FDA Preferred Term for this commodity. Hyaluronidase bears US NLM identifiers UMLS ID C0020197 and NCI Concept Code C87576. SMILES: NONE.

UNSPSC 51271503 Hyaluronidase, a Commodity code, covers enzyme preparations used in medical and pharmaceutical applications, including as adjuvants in local anesthetics, in ophthalmic surgery, and in certain injectable treatments. State and local governments procure this product primarily through health departments, hospital systems, and clinical facilities that administer injectable procedures and surgeries requiring hyaluronidase as a pharmaceutical input or therapeutic agent. The code encompasses both branded and generic formulations and may include different concentrations and delivery formats (vials, syringes, or solutions) depending on the clinical use.

The source provided contains no recent state or local contract opportunities under this code, and therefore no information on issuing-body mix, geographic concentration, or representative solicitations is available to characterize current procurement activity.